Jasvindar Singh, MD
Interventional Cardiology · Saint Louis, MONPI 1811931264
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 64.2% of it on its own, with 33 other manufacturers making up the rest. Among interventional cardiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,853 payments — averaging $375.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$447K
- Shockwave Medical, Inc$67K
- Biotronik Inc.$34K
- Boston Scientific$30K
- Penumbra, Inc.$23K
- Medtronic$23K
- plus $71K from 28 others
Across 147 payments — averaging $2021.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$122K
- Cardiovascular Systems Inc.$103K
- Abbott$46K
- Penumbra, Inc.$26K
What the payments were for
- Consulting fees$118,61217%
- Speaking & faculty fees$313,10745%
- Grants$7,5001%
- Travel & lodging$135,57819%
- Food & beverage$116,26917%
- Education$4,7851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 872 | $446,936 |
| Shockwave Medical, Inc | 118 | $66,977 |
| Biotronik Inc. | 81 | $34,246 |
| Boston Scientific | 95 | $30,403 |
| Penumbra, Inc. | 52 | $23,263 |
| Medtronic(2 entities) | 151 | $22,911 |
| Abiomed | 39 | $21,913 |
| Abbott | 338 | $21,478 |
| Cardiovascular Systems Inc. | 19 | $20,048 |
| Siemens Medical Solutions USA, Inc. | 19 | $1,938 |
| Recor Medical Inc | 11 | $999 |
| Asahi Intecc USA, Inc. | 6 | $947 |
| Cordis US CORP. | 9 | $749 |
| Heartflow, Inc. | 3 | $437 |
| Edwards Lifesciences | 5 | $358 |
| Impulse Dynamics (USA) Inc. | 4 | $341 |
| ZOLL Circulation Inc | 4 | $273 |
| Vasorum USA Inc. | 3 | $234 |
| GE HealthCare | 3 | $188 |
| Cvrx, Inc. | 2 | $183 |
| Acutus Medical, Inc. | 1 | $147 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $146 |
| Teleflex LLC | 1 | $142 |
| Avantec Vascular Corporation | 2 | $141 |
| Reflow Medical Inc | 1 | $100 |
| Spectrawave, Inc | 2 | $95 |
| Amgen | 2 | $64 |
| Cardiva Medical, Inc. | 1 | $38 |
| Surmodics, Inc. | 1 | $34 |
| Inari Medical, Inc. | 1 | $27 |
| Corindus Inc. | 1 | $26 |
| Ablative Solutions, Inc. | 1 | $26 |
| Cardinal Health 200 LLC | 1 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$146,115
- Spectranetics Undiv$81,887
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$61,546
- US Und$45,541
- GENERAL VASCULAR ACCESS$22,825
- (R11) US EQ Undivided$22,500
- (6361) Core Mobile$20,913
- Impella$20,863
- (6574) Coronary Other$17,048
- IVUS Systems$16,490
- (6554) Peripheral Vascular Undivided$16,086
- SyncVision$16,000
- Indigo System$13,661
- Coronary Orbital Atherectomy System$10,436
- Diamondback Coronary$9,424
- Indigo$8,167
- PK Papyrus$8,023
- Pulsar$7,877
- Astron; Pulsar; AstronPulsar$7,877
- Orsiro$7,877
How this compares
$695,852 in reported general payments places this provider in the 95th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $170 |
| ClopidogrelClopidogrel Bisulfate | 27 | $151 |
| Metoprolol Succinate | 22 | $147 |
| Ezetimibe | 11 | $146 |
| Rosuvastatin Calcium | 19 | $110 |
| Nitroglycerin | 15 | $90 |
| Amlodipine Besylate | 12 | $77 |
| Lisinopril | 20 | $36 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Saint Louis
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Alan ZajariasSaint Louis$203K
- Anish ThomasSaint Louis$171K
- Gus TheodosSaint Louis$165K
- Prashanth ThakkerSaint Louis$129K
- Marc SintekSaint Louis$119K
- George KichuraSaint Louis$118K
- Gil VardiSaint Louis$106K
- Anthony SonnSaint Louis$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.